when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

8,127 products tracked

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health131

Marketed
raxtozinameran
Comirnaty Omicron XBB.1.5 (raxtozinameran [INN])
Coronavirus Disease 2019 (COVID-19)$PFE PFIZER INC
Preclinical
rebastinib
rebastinib
Facioscapulohumeral Muscular Dystrophy (FSHD) Myocea Inc
pre_registration
rebisufligene etisparvovec
rebisufligene etisparvovec
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )$RARE Ultragenyx Pharmaceutical Inc.

page 250 of 271

Phase 3

Degenerative Disc Disease

DiscGenics Inc

Phase 3

reboxetine [INN]

Type 1 Narcolepsy (Narcolepsy with Cataplexy)$AXSM Axsome Therapeutics, Inc.

Preclinical

redaporfin [INN]

Bile Duct Cancer (Cholangiocarcinoma) Luzitin SA

Phase 2

Salubrin-HF (refisolone)

Premenstrual Dysphoric Disorder (PMDD)$VTGN Vistagen Therapeutics, Inc.

Phase 2

regdanvimab [INN]

Coronavirus Disease 2019 (COVID-19) Celltrion Inc

Marketed

Stivarga (regorafenib)

Recurrent Glioblastoma Multiforme (GBM) Bayer AG

Marketed

Lifyorli (relacorilant)

Epithelial Ovarian Cancer$CORT CORCEPT THERAPEUTICS INC

Phase 2

Metastatic Hepatocellular Carcinoma (HCC) Bristol-Myers Squibb Co

pre_registration

relutrigine [INN]

Epileptic Encephalopathy$PRAX Praxis Precision Medicines, Inc.

Phase 3

Prochymal (remestemcel-L)

Crohn's Disease (Regional Enteritis)$MESO MESOBLAST LTD

Phase 2

Cutaneous T-Cell Lymphoma Biossil Inc

Marketed

remimazolam besylate

Byfavo (remimazolam besylate)

Sedation Acacia Pharma Group Ltd

Phase 3

Alzheimer's Disease$ACAD ACADIA PHARMACEUTICALS INC

Phase 1

Breast Cancer$GSK GSK plc

Phase 2

Hepatocellular Carcinoma$HEPA Hepion Pharmaceuticals, Inc.

Phase 2

rentosertib acetate

rentosertib acetate

Idiopathic Pulmonary Fibrosis InSilico Medicine

Marketed

Type 2 Diabetes Padagis LLC

Phase 3

Phenylketonuria (PKU) Jnana Therapeutics Inc

Preclinical

Chronic Kidney Disease (Chronic Renal Failure)$AGNPF Algernon Health Inc.

Marketed

Augtyro (repotrectinib)

Non-Small Cell Lung Cancer Bristol-Myers Squibb Co

Phase 3

resecabtagene autoleucel

resecabtagene autoleucel [INN]

Juvenile Dermatomyositis$CABA Cabaletta Bio, Inc.

Phase 3

resiniferatoxin

resiniferatoxin [INN]

Osteoarthritis Pain Grunenthal GmbH

Phase 2

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B… SURGE Therapeutics Inc

Phase 2

resiquimod sulfate

resiquimod sulfate

Squamous Non-Small Cell Lung Cancer$EIKN Eikon Therapeutics, Inc.

Marketed

Cinqair (reslizumab)

Eosinophilic Asthma Teva Pharmaceuticals USA Inc

Phase 2

resomelagon acetate

resomelagon acetate

Rheumatoid Arthritis SynAct Pharma AB

Phase 2

respiratory syncytial virus vaccine

Respiratory Syncytial Virus (RSV) Infections$MRNA Moderna, Inc.